Literature DB >> 15981412

Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. II. Structure elucidation.

Alessandra Marazzi1, Michael Kurz, Stefania Stefanelli, Luigi Colombo.   

Abstract

During the screening program for new antibacterial agents produced by actinomycetes, GE23077 was isolated from fermentation broths of an Actinomadura sp. strain as a complex of factors A1, A2, B1, B2. NMR, MS and GC/MS analysis carried out on the isolated components led to the conclusion that GE23077 is a novel cyclic heptapeptide consisting of common and unusual amino acids. The chemical structures of the complex components were elucidated. Components A and B differ in the structure of the acyl group connected to a 2,3-diaminopropanoic acid moiety. A alpha-amino-malonic acid residue in the peptidic sequence is the origin of an isomerization process between A1 and A2 as well as B1 and B2. The chirality of the alpha-amino-malonic acid residue can be inverted easily via keto-enol tautomerism. Factors A2 and B2 should be considered as epimers of A1 and B1 respectively. By degradation studies the absolute configuration of some amino acids were determined. Chiral GC-MS and Micellar Electrokinetic Capillary Chromatography (MEKC) were used to define the absolute stereochemistries of five out of ten chiral centers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981412     DOI: 10.1038/ja.2005.30

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  2 in total

1.  Structural Reassignment and Absolute Stereochemistry of Madurastatin C1 (MBJ-0034) and the Related Aziridine Siderophores: Madurastatins A1, B1, and MBJ-0035.

Authors:  Andrew R Tyler; Hamed Mosaei; Stephanie Morton; Paul G Waddell; Corinne Wills; William McFarlane; Joe Gray; Michael Goodfellow; Jeff Errington; Nick Allenby; Nikolay Zenkin; Michael J Hall
Journal:  J Nat Prod       Date:  2017-04-11       Impact factor: 4.050

2.  GE23077 binds to the RNA polymerase 'i' and 'i+1' sites and prevents the binding of initiating nucleotides.

Authors:  Yu Zhang; David Degen; Mary X Ho; Elena Sineva; Katherine Y Ebright; Yon W Ebright; Vladimir Mekler; Hanif Vahedian-Movahed; Yu Feng; Ruiheng Yin; Steve Tuske; Herbert Irschik; Rolf Jansen; Sonia Maffioli; Stefano Donadio; Eddy Arnold; Richard H Ebright
Journal:  Elife       Date:  2014-04-22       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.